Cynthia Szewczyk

Array ( [id] => 3865426 [patent_doc_number] => 05837456 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'High affinity oligonucleotide ligands to chorionic gonadotropin hormone and related glycoprotein hormones' [patent_app_type] => 1 [patent_app_number] => 8/488402 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 21823 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837456.pdf [firstpage_image] =>[orig_patent_app_number] => 488402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3979787 [patent_doc_number] => 05958674 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections' [patent_app_type] => 1 [patent_app_number] => 8/479145 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 5396 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958674.pdf [firstpage_image] =>[orig_patent_app_number] => 479145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4318546 [patent_doc_number] => 06331273 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Remotely programmable matrices with memories' [patent_app_type] => 1 [patent_app_number] => 8/473660 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 21732 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331273.pdf [firstpage_image] =>[orig_patent_app_number] => 473660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3893063 [patent_doc_number] => 05750334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Detection of human papillomavirus mRNA in cervical smears' [patent_app_type] => 1 [patent_app_number] => 8/479567 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 1994 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750334.pdf [firstpage_image] =>[orig_patent_app_number] => 479567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4219285 [patent_doc_number] => 06111095 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Capped synthetic RNA, analogs, and aptamers' [patent_app_type] => 1 [patent_app_number] => 8/480068 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9250 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/111/06111095.pdf [firstpage_image] =>[orig_patent_app_number] => 480068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3699866 [patent_doc_number] => 05674685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'High affinity PDGF nucleic acid ligands' [patent_app_type] => 1 [patent_app_number] => 8/479725 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10496 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674685.pdf [firstpage_image] =>[orig_patent_app_number] => 479725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1523523 [patent_doc_number] => 06352854 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Remotely programmable matrices with memories' [patent_app_type] => B1 [patent_app_number] => 08/480147 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 21667 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352854.pdf [firstpage_image] =>[orig_patent_app_number] => 08480147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3915503 [patent_doc_number] => 06001988 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'High affinity nucleic acid ligands to lectins' [patent_app_type] => 1 [patent_app_number] => 8/472256 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 33014 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001988.pdf [firstpage_image] =>[orig_patent_app_number] => 472256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3645966 [patent_doc_number] => 05629158 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Solid phase diagnosis of medical conditions' [patent_app_type] => 1 [patent_app_number] => 8/477270 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 22 [patent_no_of_words] => 14534 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629158.pdf [firstpage_image] =>[orig_patent_app_number] => 477270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770449 [patent_doc_number] => 05807689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Methods for identifying compounds that modulate metabotropic glutamate receptor activity' [patent_app_type] => 1 [patent_app_number] => 8/486270 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22836 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807689.pdf [firstpage_image] =>[orig_patent_app_number] => 486270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4027721 [patent_doc_number] => 05883225 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Relating to the detection of viruses' [patent_app_type] => 1 [patent_app_number] => 8/468042 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3463 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/883/05883225.pdf [firstpage_image] =>[orig_patent_app_number] => 468042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4136077 [patent_doc_number] => 06121419 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Compositions and methods for detecting gene rearrangements and translocations' [patent_app_type] => 1 [patent_app_number] => 8/465713 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 27813 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121419.pdf [firstpage_image] =>[orig_patent_app_number] => 465713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1365593 [patent_doc_number] => 06570000 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-27 [patent_title] => 'DNA encoding the T cell surface protein CD4 and use of fragments of CD4 in the treatment of AIDS' [patent_app_type] => B1 [patent_app_number] => 08/470998 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 22301 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/570/06570000.pdf [firstpage_image] =>[orig_patent_app_number] => 08470998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3865750 [patent_doc_number] => 05837472 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Nucleotide sequences coding for a protein with urease activity' [patent_app_type] => 1 [patent_app_number] => 8/467283 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5720 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837472.pdf [firstpage_image] =>[orig_patent_app_number] => 467283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3872158 [patent_doc_number] => 05824518 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Nucleic acid sequence amplification methods' [patent_app_type] => 1 [patent_app_number] => 8/469067 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 28 [patent_no_of_words] => 23560 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824518.pdf [firstpage_image] =>[orig_patent_app_number] => 469067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3806540 [patent_doc_number] => 05811237 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Nucleotide sequences coding for a protein with urease activity' [patent_app_type] => 1 [patent_app_number] => 8/470245 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5623 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811237.pdf [firstpage_image] =>[orig_patent_app_number] => 470245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3766996 [patent_doc_number] => 05773257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Method for producing primed nucleic acid templates' [patent_app_type] => 1 [patent_app_number] => 8/469564 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 12880 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773257.pdf [firstpage_image] =>[orig_patent_app_number] => 469564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3757030 [patent_doc_number] => 05843653 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Method for detecting a target molecule in a sample using a nucleic acid ligand' [patent_app_type] => 1 [patent_app_number] => 8/469609 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 36 [patent_no_of_words] => 45249 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843653.pdf [firstpage_image] =>[orig_patent_app_number] => 469609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3630931 [patent_doc_number] => 05686592 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'High-affinity oligonucleotide ligands to immunoglobulin E (IgE)' [patent_app_type] => 1 [patent_app_number] => 8/471985 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15546 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686592.pdf [firstpage_image] =>[orig_patent_app_number] => 471985 [rel_patent_id] =>[rel_patent_doc_number] =>)